Vaccination after infection may reduce likelihood of long COVID symptoms … 11% of COVID patients were readmitted or died after hospital discharge, study finds … Oral anticoagulant use has increased...
Time-restricted eating reduces CVD risk for older breast cancer survivors
May 19, 2022
Cardiovascular disease risk for breast cancer survivors fell by 15% following an eight-week time-restricted eating intervention.
Paxlovid keeping hospitalizations, deaths low as COVID-19 infections rise, White House official says
By
Alicia Lasek (f3)
May 19, 2022
Clinicians are writing 20,000 prescriptions for Paxlovid each day, helping to keep severe outcomes in check, the COVID-19 Response Coordinator said Wednesday.
Study pinpoints prescribing practices that may raise disability risk for LTC residents
By
Alicia Lasek (f3)
May 19, 2022
Polypharmacy and the use of drugs with sedative or anticholinergic properties were tied to increased odds of functional disability and the need for LTC services.
Candida auris outbreaks reported across Nevada skilled nursing and acute-care facilities
By
Alicia Lasek (f3)
May 19, 2022
Nevada health officials have been investigating outbreaks of Candida auris since mid-April in “several” long-term care facilities, a local news outlet reports.
MRSA and VRE persist in resident rooms, nursing home study finds
By
Alicia Lasek (f3)
May 18, 2022
Two common types of antibiotic-resistant bacteria can linger in resident rooms — even during changes of occupancy, a new facility study finds.
Tooth survival after root canal varies widely across U.S. regions
By
Alicia Lasek (f3)
May 18, 2022
Tooth longevity ranges from about nine to 20 years after a root canal, depending in part on where one lives, a new study has found.
LTC staff to receive free behavioral health training in new federal program
By
Alicia Lasek (f3)
May 17, 2022
The new $15 million program will focus on workforce skills in an effort to strengthen behavioral healthcare delivery in long-term care facilities, HHS announced Monday.
FDA approves diabetes drug with evidence of superior blood sugar control
By
Alicia Lasek (f3)
May 17, 2022
Mounjaro was more effective than other type 2 diabetes drugs at helping clinical trial participants control blood sugar and lose weight, the FDA reports.
Clinical briefs for Tuesday, May 17
By
Alicia Lasek (f3)
May 17, 2022
Supporting sleep continuity may improve daytime dementia symptoms … Research urgently needed on long COVID among LTC residents, clinicians say … FDA greenlights first OTC COVID test that also detects...